• #1195617
  • Sanofi Pasteur #63361024310

Vaxelis™ DTAP-IPV/HIB/HEB Vaccine dip,pert(a)tet/hepB/pol/Hib/PF Injection Single Dose Vial 0.5 mL

VAXELIS DTAP-IPV/HIB/HEPB, SDV0.5ML (10/CT)

Features
  • VAXELIS (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) is a vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b (Hib).
  • VAXELIS is approved for use as a 3-dose series in children 6 weeks through 4 years of age (prior to the 5th birthday).
  • VAXELIS may reduce the number of shots that infants and parents must endure in the first 6 months—with as few as 2 injections per visit
  • More …
  Log In to Order
or

Product Specifications


McKesson #1195617
Manufacturer #63361024310
BrandVaxelis™
ManufacturerSanofi Pasteur
Country of OriginUnknown
Alternate Manufacturer Number2337657
ApplicationDTAP-IPV/HIB/HEB Vaccine
Container TypeSingle Dose Vial
Dosage FormInjection
Generic Drug Code40619
Generic Drug Namedip,pert(a)tet/hepB/pol/Hib/PF
NDC Number63361-243-10
Storage RequirementsRequires Refrigeration
TypeIntramuscular
UNSPSC Code51202101
Volume0.5 mL
Features
  • VAXELIS (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) is a vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b (Hib).
  • VAXELIS is approved for use as a 3-dose series in children 6 weeks through 4 years of age (prior to the 5th birthday).
  • VAXELIS may reduce the number of shots that infants and parents must endure in the first 6 months—with as few as 2 injections per visit

Professionals Also Viewed